McKesson Corporation (MCK)VA awarded $1.19B

$1.19B

committed so far

Signed

Jul 1, 2026

Updated

Sep 4, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 7, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
2. Mar 27, 2026CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
3. Apr 1, 2026Federal contract · $1.2B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.19B obligated to date
4. May 1, 2026Federal contract · $1.4B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.4B obligated to date
5. May 7, 2026Company filing · Form 8-K · ResultsReported its results
6. May 26, 2026Insider · 2 peopleInsiders: 2 sales (~$4.5M)
7. Jun 1, 2026Federal contract · $1.2B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.19B obligated to date
8. Jun 1, 2026Insider · 2 peopleInsiders: 2 sales (~$1.4M)
9. Jun 2, 2026InsiderOfficer sold ~$514K of MCK shares in the open market
10. Jun 5, 2026InsiderOfficer sold ~$102K of MCK shares in the open market
11. Jun 9, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
12. Jun 9, 2026InsiderCEO sold ~$3.76M of MCK shares in the open market
13. Jun 10, 2026FDARecall: Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH…
14. Jun 15, 2026CongressDisclosed sale of MCK — reported range $1,001 - $15,000
15. Jun 17, 2026InsiderCEO sold ~$6.56M of MCK shares in the open market
16. Jun 29, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On June 29, 2026, Thomas L. Rodgers, the company’s Executive Vice President, Chief Strategy and Business Development Officer and a named executive officer, gave notice of his intention to retire from that role.”
17. Jul 1, 2026 · this disclosureFederal contract · $1.2B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.19B obligated to date

What came next

1. Jul 7, 2026InsiderCEO sold ~$6.72M of MCK shares in the open market
2. Jul 8, 2026CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
3. Aug 1, 2026Federal contract · $1.2B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.16B obligated to date
4. Aug 3, 2026Government · Federal Register ruleStreamlining Probationary and Trial Period Appeals
5. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
6. Aug 10, 2026InsiderDirector sold ~$269K of MCK shares in the open market
7. Sep 8, 2026InsiderOfficer sold ~$99K of MCK shares in the open market

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for McKesson Corporation

For McKesson Corporation, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 47 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCK page.

How this filing works

• Contract ceiling vs obligated amount

Other disclosures at McKesson Corporation

• USAspending.gov award recordOct 5, 2026
• SEC Form 4Sep 10, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its MCK page.